Biotherapies in large vessel vasculitis
- 1 June 2016
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 15 (6) , 544-551
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Design of the Tocilizumab in Giant Cell Arteritis TrialInternational Journal of Rheumatology, 2013
- Anti-interleukin 6 receptor therapy as rescue treatment for giant cell arteritisAnnals of the Rheumatic Diseases, 2011
- Successful use of tocilizumab in polymyalgic onset biopsy positive GCA with large vessel involvementBMJ Case Reports, 2011
- Relapsing polychondritis: An autoimmune disease with many facesAutoimmunity Reviews, 2010
- Sustained response to infliximab in a patient with relapsing polychondritis with aortic involvementRheumatology, 2009
- Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-upAnnals of the Rheumatic Diseases, 2008
- AortitisCirculation, 2008
- Tumor Necrosis Factor Gene Polymorphisms in Tunisian Patients With Behçet’s DiseaseHuman Immunology, 2007
- Behçet's disease with life-threatening haemoptoe and pulmonary aneurysms: complete remission after infliximab treatmentAnnals of the Rheumatic Diseases, 2006
- Infliximab in Takayasu arteritis: a safe alternative?Clinical Rheumatology, 2006